Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Guido Martignoni is active.

Publication


Featured researches published by Guido Martignoni.


The American Journal of Surgical Pathology | 2018

Challenges in pathologic staging of renal cell carcinoma: A study of interobserver variability among urologic pathologists

Sean R. Williamson; Priya Rao; Ondrej Hes; Jonathan I. Epstein; Steven C. Smith; Maria M. Picken; Ming Zhou; Maria S. Tretiakova; Satish K. Tickoo; Ying Bei Chen; Victor E. Reuter; Stewart Fleming; Fiona Maclean; Nilesh S. Gupta; Naoto Kuroda; Brett Delahunt; Rohit Mehra; Christopher G. Przybycin; Liang Cheng; John N. Eble; David J. Grignon; Holger Moch; José I. López; Lakshmi P. Kunju; Pheroze Tamboli; John R. Srigley; Mahul B. Amin; Guido Martignoni; Michelle S. Hirsch; Stephen M. Bonsib

Staging criteria for renal cell carcinoma differ from many other cancers, in that renal tumors are often spherical with subtle, finger-like extensions into veins, renal sinus, or perinephric tissue. We sought to study interobserver agreement in pathologic stage categories for challenging cases. An online survey was circulated to urologic pathologists interested in kidney tumors, yielding 89% response (31/35). Most questions included 1 to 4 images, focusing on: vascular and renal sinus invasion (n=24), perinephric invasion (n=9), and gross pathology/specimen handling (n=17). Responses were collapsed for analysis into positive and negative/equivocal for upstaging. Consensus was regarded as an agreement of 67% (2/3) of participants, which was reached in 20/33 (61%) evaluable scenarios regarding renal sinus, perinephric, or vein invasion, of which 13/33 (39%) had ≥80% consensus. Lack of agreement was especially encountered regarding small tumor protrusions into a possible vascular lumen, close to the tumor leading edge. For gross photographs, most were interpreted as suspicious but requiring histologic confirmation. Most participants (61%) rarely used special stains to evaluate vascular invasion, usually endothelial markers (81%). Most agreed that a spherical mass bulging well beyond the kidney parenchyma into the renal sinus (71%) or perinephric fat (90%) did not necessarily indicate invasion. Interobserver agreement in pathologic staging of renal cancer is relatively good among urologic pathologists interested in kidney tumors, even when selecting cases that test the earliest and borderline thresholds for extrarenal extension. Disagreements remain, however, particularly for tumors with small, finger-like protrusions, closely juxtaposed to the main mass.


Annales De Pathologie | 2014

Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations

Nathalie Rioux-Leclercq; Algaba Ferran; Amin Mahul; Pedram Argani; Athanase Billis; Stephen M. Bonsib; Liang Cheng; John C. Cheville; John N. Eble; L. Egevad; Jonathan I. Epstein; David J. Grignon; Ondřej Hes; Peter A. Humphrey; Cristina Magi-Galluzzi; Guido Martignoni; Jesse K. McKenney; Maria J. Merino; Holger Moch; Rodolfo Montironi; George J. Netto; Reuter; Hemamali Samaratunga; Steven S. Shen; John R. Srigley; Pheroze Tamboli; Puay Hoon Tan; Satish K. Tickoo; Kiril Trpkov; Ming Zhou

During the last 30 years many advances have been made in kidney tumor pathology. In 1981, 9 entities were recognized in the WHO Classification. In the latest classification of 2004, 50 different types have been recognized. Additional tumor entities have been described since and a wide variety of prognostic parameters have been investigated with variable success; however, much attention has centered upon the importance of features relating to both stage and grade. The International Society of Urological Pathology (ISUP) recommends after consensus conferences the development of reporting guidelines, which have been adopted worldwide ISUP undertook to review all aspects of the pathology of adult renal malignancy through an international consensus conference to be held in 2012. As in the past, participation in this consensus conference was restricted to acknowledged experts in the field.


Archive | 2009

Oncocytoma-like Angiomyolipoma

Guido Martignoni; M Pea; Franco Bonetti; Matteo Brunelli; John N. Eble


Archive | 2009

Carcinoid Tumors of the Urinary Bladder

Guido Martignoni; John N. Eble


American Journal of Cancer Research | 2014

Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors

Fiorini C; Massari F; Serena Pedron; Sanavio S; Ciccarese C; Porcaro Ab; Artibani W; Bertoldo F; Zampini C; Sava T; Ficial M; Anna Caliò; Marco Chilosi; D'Amuri A; Sanguedolce F; Giampaolo Tortora; Aldo Scarpa; Brett Delahunt; Porta C; Guido Martignoni; Matteo Brunelli


Moch, H; Amin, M B; Argani, P; Cheville, J; Delahunt, B; Martignoni, G; Medeiros, L J; Srigley, J R; Tan, P H; Tickoo, S K (2016). Renal cell tumours. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 14-43. | 2016

Renal cell tumours

Holger Moch; Mahul B. Amin; Pedram Argani; John C. Cheville; Brett Delahunt; Guido Martignoni; L. J. Medeiros; John R. Srigley; Puay Hoon Tan; Satish K. Tickoo


ESGAR 2016 - 27th Annual Meeting and Postgraduate Course | 2016

Tumour thrombosis: an uncommon finding associated with pancreatic tumours

Riccardo De Robertis Lombardi; Mirko D'Onofrio; P. Tinazzi Martini; Salvatore Paiella; S Gobbo; Paola Capelli; Guido Martignoni; Giovanni Butturini; Claudio Bassi; Aldo Scarpa; Paolo Pederzoli


PMC | 2015

Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder

Francesco Massari; Emilio Bria; Chiara Ciccarese; Enrico Munari; Alessandra Modena; Valentina Zambonin; Isabella Sperduti; Walter Artibani; Liang Cheng; Guido Martignoni; Giampaolo Tortora; Matteo Brunelli


Archive | 2015

Original Article Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification

Matteo Brunelli; Alessia Nottegar; Giuseppe Bogina; Anna Caliò; Luca Cima; Albino Eccher; Lisa Marcolini; Aldo Scarpa; Serena Pedron; Eleonora Brunello; Sakari Knuutila; Caterina Marchiò; Emilio Bria; Annamaria Molino; Luisa Carbognin; Giampaolo Tortora; Bharat Jasani; Keith Miller; Ibrahim Merdol; Lucia Zanatta; Licia Laurino; Tiina Wirtanen; Marcella Marconi; Marco Chilosi; Erminia Manfrin; Guido Martignoni; Franco Bonetti; Sacro Cuore; S. Maria


Archive | 2014

Clearcellpapillaryrenalcellcarcinoma:micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal

Enrico Munari; Luigi Marchionni; Apurva Chitre; Masamichi Hayashi; Guido Martignoni; Matteo Brunelli; Stefano Gobbo; Pedram Argani; Mohamad Allaf; Mohammad O. Hoque; George J. Netto

Collaboration


Dive into the Guido Martignoni's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Satish K. Tickoo

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Holger Moch

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giampaolo Tortora

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge